Product Information
COLESEVELAM HCL 3.75 G PACKET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.7042 per EA under NDC 68462062030. Its NADAC has been published 416 times since Oct 17, 2018.
FDA first approved this application on Jul 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3.75 g/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462062030
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202190FDA Approved
7/16/2018
TE Code
AB
On Market Since
7/16/2018
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM HCL 3.75 G PACKET has been published 416 times since Oct 17, 2018, and over the history we have for it it has declined 81.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7042 per EA |
|---|---|
| All-time high | $15.5351 (Feb 13, 2019) |
| All-time low | $2.4176 (May 20, 2026) |
| 52-week high | $2.7662 |
| 52-week low | $2.4176 |
| Median price | $5.3441 |
| Average price | $6.7544 |
| Largest weekly change | +44.2% (Feb 23, 2022) |
| Weeks tracked | 416 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colesevelam Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Colesevelam Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESEVELAM HCL 3.75 G PACKET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM HCL 3.75 G PACKET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.7042 per EA (NDC 68462062030), effective Sep 30, 2026.
How has the price of COLESEVELAM HCL 3.75 G PACKET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM HCL 3.75 G PACKET has declined 81.9%. It has been tracked across 416 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for COLESEVELAM HCL 3.75 G PACKET?
Since Oct 17, 2018, the NADAC for COLESEVELAM HCL 3.75 G PACKET has ranged from a low of $2.4176 (May 20, 2026) to a high of $15.5351 (Feb 13, 2019), with a median of $5.3441 per EA.
Are there cheaper alternatives to COLESEVELAM HCL 3.75 G PACKET?
No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM HCL 3.75 G PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM HCL 3.75 G PACKET?
COLESEVELAM HCL 3.75 G PACKET (NDC 68462062030) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.